Efficacy and Safety of Secukinumab in Patients with Spondyloarthritis and Enthesitis at the Achilles Tendon: 52-weeks Results from a Randomized, Placebo-controlled Phase 3b Trial

被引：0
|
作者：
Behrens, Frank [1 ,2 ]
Sewerin, Philipp [3 ,4 ]
De Miguel, Eugenio [5 ]
Patel, Yusuf [6 ]
Batalov, Anastas [7 ]
Dokoupilova, Eva [8 ,9 ]
Kleinmond, Christine [10 ]
Pournara, Effie [11 ]
Shekhawat, Ankita [12 ]
Jentzsch, Claudia [13 ]
Wiedon, Annette [14 ]
Baraliakos, Xenofon [15 ]
机构：
[1] Goethe Univ, CIRI Rheumatol, Frankfurt, Germany
[2] Goethe Univ, Fraunhofer TMP, Frankfurt, Germany
[3] Univ Hosp Dusseldorf, Dept Rheumatol, Dusseldorf, Germany
[4] Univ Hosp Dusseldorf, Hiller Res Unit, Dusseldorf, Germany
[5] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain
[6] Hull Univ Teaching Hosp, Kingston Upon Hull, East Yorkshire, England
[7] Med Univ Plovdiv, Univ Hosp Kaspela, Plovdiv, Bulgaria
[8] Med Plus Sro, Uherske Hradiste, Czech Republic
[9] Univ Vet & Pharmaceut Sci, Fac Pharm, Dept Pharmaceut, Uherske Hradiste, Czech Republic
[10] ClinProject GmbH, Eurasburg, Germany
[11] Novartis Pharma AG, Basel, Switzerland
[12] Novartis Healthcare Private Ltd, Hyderabad, Telangana, India
[13] Novartis Pharma GmbH, Nurnberg, Germany
[14] Novartis Pharma GmbH, Nurnberg, Germany
[15] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0882
引用
收藏
页数：3
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF GOLIMUMAB IN PATIENTS WITH ACTIVE, VERY EARLY PERIPHERAL SPONDYLOARTHRITIS: FIRST RESULTS FROM THE CRESPA STUDY, A MONOCENTRIC, PLACEBO-CONTROLLED RANDOMIZED TRIAL
    Carron, P.
    Varkas, G.
    Cypers, H.
    Van Praet, L.
    Elewaut, D.
    Van den Bosch, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 802 - 802
  • [32] Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study
    Passeron, Thierry
    Reinhardt, Maximilian
    Ehst, Benjamin
    Weiss, Jonathan
    Sluzevich, Jason
    Sticherling, Michael
    Reygagne, Pascal
    Wohlrab, Johannes
    Hertl, Michael
    Fazel, Nasim
    Muscianisi, Elisa
    Fan, Heng
    Hampele, Isabelle
    Compagno, Nicolo
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (05) : 680 - 690
  • [33] Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in Japan
    Nakaoka, Yoshikazu
    Isobe, Mitsuaki
    Takei, Syuji
    Tanaka, Yoshiya
    Ishii, Tomonori
    Yokota, Shumpei
    Nomura, Akira
    Yoshida, Seitaro
    Nishimoto, Norihiro
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [34] Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial
    Shestakova, Marina
    Kvasnikov, Boris
    Erina, Ekaterina
    Isachenko, Elena
    Andreev, Alexander
    Study Investigators
    BMJ OPEN DIABETES RESEARCH & CARE, 2023, 11 (03)
  • [35] Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study
    Ohtsuki, Mamitaro
    Morita, Akimichi
    Abe, Masatoshi
    Takahashi, Hidetoshi
    Seko, Noriko
    Karpov, Alexander
    Shima, Tomohiro
    Papavassilis, Charis
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2014, 41 (12): : 1039 - 1046
  • [36] Improvement of platysma prominence with onabotulinumtoxinA: Safety and efficacy results from a randomized, double-blinded, placebo-controlled phase 3 trial
    Fabi, Sabrina
    Humphrey, Shannon
    Biesman, Brian
    George, Rosalyn
    Latowsky, Brenda
    Weiss, Robert A.
    Park, Grace S.
    Shimoga, Sandhya
    Lee, Elisabeth
    Jierjian, Edward
    Tong, Warren
    Hopfinger, Rene
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (02) : 285 - 291
  • [37] Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study
    Deodhar, Atul
    Blanco, Ricardo
    Dokoupilova, Eva
    Hall, Stephen
    Kameda, Hideto
    Kivitz, Alan J.
    Poddubnyy, Denis
    van de Sande, Marleen
    Wiksten, Anna S.
    Porter, Brian O.
    Richards, Hanno B.
    Haemmerle, Sibylle
    Braun, Juergen
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (01) : 110 - 120
  • [38] EFFICACY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS: RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA)
    Ruperto, N.
    Chertok, E.
    Dehoorne, J.
    Horneff, G.
    Kallinich, T.
    Louw, I.
    Compeyrot-Lacassagne, S.
    Lauwerys, B.
    Martin, N.
    Marzan, K.
    Knibbe, W.
    Martin, R.
    Zhu, X.
    Whelan, S.
    Pricop, L.
    Martini, A.
    Lovell, D. J.
    Brunner, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 145 - 146
  • [39] EFFICACY AND SAFETY OF TABALUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM 2 PHASE 3, 52-WEEK, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIALS
    Isenberg, D.
    Merrill, J.
    Hoffman, R.
    Linnik, M.
    Morgan-Cox, M.
    Veenhuizen, M.
    Iikuni, N.
    Dickson, C.
    Silk, M.
    Wallace, D.
    Doerner, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 141 - 141
  • [40] Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
    MaassenVanDenBrink, Antoinette
    Terwindt, Gisela M.
    Cohen, Joshua M.
    Barash, Steve
    Campos, Verena Ramirez
    Galic, Maja
    Ning, Xiaoping
    Karppa, Mikko
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
12345